| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating expenses: | ||||||||
Research and development | ||||||||
159,834 | 143,403 | 126,679 | 105,388 | 77,642 | 55,283 | 0 | 0 | 0 |
In process research and development | ||||||||
5,405 | 3,600 | 2,000 | 10,261 | 29,761 | 49,659 | 0 | 0 | 0 |
General and administrative | ||||||||
41,850 | 39,136 | 41,480 | 54,548 | 49,481 | 44,051 | 0 | 0 | 0 |
Total operating expenses | ||||||||
207,089 | 186,139 | 170,159 | 170,197 | 156,884 | 148,993 | 0 | 0 | 0 |
Loss from operations | ||||||||
-207,089 | -186,139 | -170,159 | -170,197 | -156,884 | -148,993 | 0 | 0 | 0 |
Interest income | ||||||||
- | - | - | - | - | - | - | - | 0 |
Other income, net | ||||||||
5,319 | 5,832 | 5,756 | 4,892 | 3,341 | 2,024 | 0 | 0 | 0 |
Net loss | ||||||||
-201,770 | -180,307 | -164,403 | -165,305 | -153,543 | -146,969 | 0 | 0 | 0 |
Other comprehensive income: | ||||||||
Foreign currency translation, net of tax | ||||||||
0 | - | - | - | - | - | - | - | - |
Other comprehensive income (loss) | ||||||||
-584 | 319 | 621 | 792 | 0 | - | 0 | 0 | - |
Unrealized gain (loss) on marketable securities, net of tax | ||||||||
-485 | 331 | 621 | 792 | 0 | - | 0 | 0 | - |
Comprehensive loss | ||||||||
-202,354 | -179,988 | -164,310 | -164,812 | -153,464 | -147,030 | 0 | 0 | 0 |
Net loss per share, basic and diluted | ||||||||
-0.87 | -0.85 | -0.80 | -0.74 | -0.90 | -4.76 | -7.69 | -5.65 | -4.49 |
Weighted average common shares outstanding, basic and diluted | ||||||||
61,890 | 61,622 | 60,755 | 60,265 | 36,317 | 8,003 | 6,423 | 5,795 | 5,797 |